| Title | Matrix metalloproteinases and cardiovascular diseases. | | Author(s) | Papazafiropoulou A, Tentolouris N | | Institution | 1 Department of Propaedeutic Medicine, Laiko Hospital, Athens University Medical Schol, Athens, Greece. | | Source | Hippokratia 2009 Apr; 13(2):76-82. | | Abstract | Matrix metalloproteinases (MMPs) are extracellular enzymes that are important in many physiologic and pathologic processes. Their activity is regulated mainly by tissue inhibitors of metalloproteinases (TIMPs). MMPs expression is related with the classical cardiovascular risk factors as well as with inflammation. They play a central role in atherosclerosis, plaque formation, platelet aggregation, acute coronary syndrome, restenosis, aortic aneurysms and peripheral vascular disease. Many studies have shown that commonly prescribed antihypertensive medications, glitazones and statins may influence MMPs activity. The aim of the review is to present literature data on the role of MMPs and their inhibitors in cardiovascular disease. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19561775 |
|
